These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21352854)

  • 1. Triggering of toll-like receptor signaling pathways in T cells contributes to the anti-tumor efficacy of T cell responses.
    Salem ML
    Immunol Lett; 2011 Jun; 137(1-2):9-14. PubMed ID: 21352854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the role of Toll-like receptors in modulation of T cell responses.
    Kulkarni R; Behboudi S; Sharif S
    Cell Tissue Res; 2011 Jan; 343(1):141-52. PubMed ID: 20680345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.
    Conroy H; Marshall NA; Mills KH
    Oncogene; 2008 Jan; 27(2):168-80. PubMed ID: 18176598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct and indirect role of Toll-like receptors in T cell mediated immunity.
    Xu D; Liu H; Komai-Koma M
    Cell Mol Immunol; 2004 Aug; 1(4):239-46. PubMed ID: 16225766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation.
    Goldstein DR; Palmer SM
    J Heart Lung Transplant; 2005 Nov; 24(11):1721-9. PubMed ID: 16297771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Innate immunity: structure and function of TLRs].
    Delneste Y; Beauvillain C; Jeannin P
    Med Sci (Paris); 2007 Jan; 23(1):67-73. PubMed ID: 17212934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell-dependent and -independent IgA responses: role of TLR signalling.
    Bessa J; Bachmann MF
    Immunol Invest; 2010; 39(4-5):407-28. PubMed ID: 20450285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors and genital tract infection.
    Sonnex C
    Int J STD AIDS; 2010 Mar; 21(3):153-7. PubMed ID: 20215617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells from bench to bedside and back.
    Adema GJ
    Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR based therapeutics.
    Dunne A; Marshall NA; Mills KH
    Curr Opin Pharmacol; 2011 Aug; 11(4):404-11. PubMed ID: 21501972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
    Jasani B; Navabi H; Adams M
    Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential immune effects mediated by Toll-like receptors stimulation in precursor B-cell acute lymphoblastic leukaemia.
    Corthals SL; Wynne K; She K; Shimizu H; Curman D; Garbutt K; Reid GS
    Br J Haematol; 2006 Feb; 132(4):452-8. PubMed ID: 16412017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of B-cell responses by Toll-like receptors.
    Pasare C; Medzhitov R
    Nature; 2005 Nov; 438(7066):364-8. PubMed ID: 16292312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond.
    Lahiri A; Das P; Chakravortty D
    Vaccine; 2008 Dec; 26(52):6777-83. PubMed ID: 18835576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.
    Ghosh TK; Mickelson DJ; Fink J; Solberg JC; Inglefield JR; Hook D; Gupta SK; Gibson S; Alkan SS
    Cell Immunol; 2006 Sep; 243(1):48-57. PubMed ID: 17250816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BDCA-2 signaling inhibits TLR-9-agonist-induced plasmacytoid dendritic cell activation and antigen presentation.
    Jähn PS; Zänker KS; Schmitz J; Dzionek A
    Cell Immunol; 2010; 265(1):15-22. PubMed ID: 20673884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A balance between tissue-destructive and tissue-protective immunities: a role of toll-like receptors in regulation of adaptive immunity.
    Seledtsov VI; Seledtsova GV
    Immunobiology; 2012 Apr; 217(4):430-5. PubMed ID: 22099351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient stimulation of T cell responses by human IFN-alpha-induced dendritic cells does not require Toll-like receptor triggering.
    Bracci L; Schumacher R; Provenzano M; Adamina M; Rosenthal R; Groeper C; Zajac P; Iezzi G; Proietti E; Belardelli F; Spagnoli GC
    J Immunother; 2008 Jun; 31(5):466-74. PubMed ID: 18463538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor regulation of effector T lymphocyte function.
    Reynolds JM; Dong C
    Trends Immunol; 2013 Oct; 34(10):511-9. PubMed ID: 23886621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.